FDA says Guillain-Barre syndrome is possible risk of Pfizer’s RSV vaccine for older adults

The FDA sees a potential risk and has asked Pfizer to conduct a safety study on Guillain-Barre after a potential

Read more

CDC urges people with weak immune systems to take extra precautions after Covid subvariants knock out Evusheld

Evusheld was a key antibody treatment taken by people with weak immune systems as an added layer of protection. Source

Read more